Dr. Nicole D. Fleming, MD

Dr. Fleming practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Fleming's NPI, 1881890796, was assigned on June 26, 2007. Dr. Fleming holds Washington license MD61572096.

Dr. Fleming's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Fleming's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Fleming is also affiliated with Houston Methodist Sugar Land Hospital. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Fleming to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Fleming is licensed in Washington.

CMS data shows 143 Medicare services from Dr. Fleming across 5 procedure codes in 2024, for 83 Medicare patients. Medicare paid $12,153 for them.

CMS counts 83 Medicare patients who saw Dr. Fleming in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 58, with 100% women.

In 2024, Dr. Fleming wrote 104 Medicare Part D claims for 37 patients. 73% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $230 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Fleming for performance year 2024, reported through an alternative payment model (APM). Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 67 general payments to Dr. Fleming from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. TESARO, Inc. paid the most, $7,817.